BusStim-LLC-logo

Our Business Model

Our Therapeutic Areas of Focus

Oncology

Neurology

Cardio/Metabolic

Immunology/Inflammation


Infectious Diseases

BusStim’s- New Company creation

From University/Academia

  • Licensing agreements or options
  • Negotiated milestones and timeline as key component of the agreement
  • Build a C-Suite Team around the Asset and Scientific Founder

From Pharma

  • Finding an Investment Partner
  • Licensing agreements
  • Negotiated Payments/milestones and timeline as key component of the agreement

BusStim’s- Risk Sharing Partnering for Existing Companies


Co-Development & Collaboration Agreement with existing Biotech companies and Academic Investigators/Founders

  • Founder shares Equity positions which vest with completion of milestones
  • Company Creation & Value Add – Getting ready for Funding
  • Build out or supplement the Management team
  • Develop or enhance the Product Development Plan
  • Raise equity capital or non-diluted funding – Seed/Series A 
  • Oversee and supplement Drug Development Activities
  • Raise equity capital – Series B (If needed)
  • Obtain Pharma Deal
  • And other success base options

 


Share by: